Tilray buying eight Anheuser-Busch brands: CEO explains how he plans to make 'craft beer cool again'

In This Article:

Tilray Brands (TLRY) is acquiring eight beer and beverage brands from Anheuser-Busch (BUD), including popular names such as Shock Top and Red Hook. Tilray CEO Irwin Simon joins Yahoo Finance Live to discuss the deal. Irwin says the brands will help diversify the company's portfolio, adding that he sees "such opportunity within the craft beer business." Simon says Tilray's strategy is "how do we make craft beer cool again?" Irwin says they will try to make "craft beer cool again" by "coming up with unique products, connecting with the consumer, and, with that, we will hopefully get these products growing in the right direction." However, Irwin does say that will it cost the company money to improve packaging and market the brands.

Video Transcript

JULIE HYMAN: You're watching Yahoo Finance, I'm Julie Hyman. Well, Anheuser-Busch announcing they're going to sell eight of their beverage labels to Tilray Brands. The portfolio includes popular names like Shock Top and Red Hook. The deal expected to close this year also included current employees, breweries, and brewpubs related to those beverage makers.

And joining me now to talk all about it is Irwin Simon. He is the CEO of Tilray. And you see some of the cans there of those beverages behind him and some of the existing brands as well. Irwin, it's great to see you. This is just the latest deal that you have done. Talk to me about how this one fits into not just the existing portfolio, but the strategy overall of the company.

IRWIN SIMON: So Julie, good afternoon. Great to see you. And here's a lot of our great beer brands and our spirit brands. Listen, I think the exciting thing is, and you've seen what with Hain Celestial, what it was able to do is bring a bunch of brands and diversify the company into multiple categories.

Not dissimilar here. When I got to a free in 2018, we were a $50 million business. We're approaching close to a billion in size. And one of the challenges I ran into was with cannabis, was not knowing what legalization was going to happen.

Legalization happened in Canada. Medical legalization happened in Europe in multiple countries. But everybody was waiting for the US. And with that, it took a lot of predictability away from earnings and revenue-generating. And I think you saw so many cannabis companies where their stocks just got hit hard.

And what I wanted to do was make sure we were not dependent upon legalization. We had a good income stream. We had revenue stream. We had predictability of earnings, and I want to diversify the company. But what was important, that we had adjacencies out there that they could bring it all together.